Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety, Tolerability, Pharmacokinetics and Pharmacodynamics”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03457649
What this trial is testing

IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers

Who this might be right for
Healthy Volunteers
argenx 62
Early research (Phase 1)Study completedNCT01710826
What this trial is testing

A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of Genz-682452 in Healthy Volunteers

Who this might be right for
Healthy
Genzyme, a Sanofi Company 36
Early research (Phase 1)Study completedNCT03040635
What this trial is testing

Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Risdiplam (RO7034067) in Healthy Japanese Participants

Who this might be right for
Healthy Volunteers
Hoffmann-La Roche 24
Early research (Phase 1)Study completedNCT04451408
What this trial is testing

LY3372993 in Participants With Alzheimer's Disease (AD) and Healthy Participants

Who this might be right for
Alzheimer DiseaseHealthy
Eli Lilly and Company 139
Early research (Phase 1)Looking for participantsNCT07584876
What this trial is testing

Clinical Study in Healthy Participants

Who this might be right for
HV
Shanghai Argo Biopharmaceutical Co., Ltd. 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT06181136
What this trial is testing

Study of DNL126 in Pediatric Participants With Mucopolysaccharidosis Type IIIA (Sanfilippo Syndrome Type A)

Who this might be right for
Mucopolysaccharidosis Type IIIA
Denali Therapeutics Inc. 20
Early research (Phase 1)Study completedNCT05807971
What this trial is testing

Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ATH-063 in Healthy Subjects

Who this might be right for
Inflammatory Bowel DiseasesCrohn DiseaseUlcerative Colitis+1 more
Athos Therapeutics Inc 76
Early research (Phase 1)Study completedNCT05659264
What this trial is testing

Evaluate the Safety of mRNA-0184 in Participants With Heart Failure

Who this might be right for
Chronic Heart Failure
ModernaTX, Inc. 48
Early research (Phase 1)Study completedNCT05450198
What this trial is testing

Multiple Rising Dose Study of MK-6194 in Participants With Atopic Dermatitis (MK-6194-008)

Who this might be right for
Dermatitis, Atopic
Merck Sharp & Dohme LLC 72
Testing effectiveness (Phase 2)WithdrawnNCT04607655
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered GB1211 in Participants With Suspected or Confirmed Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
Galecto Biotech AB
Testing effectiveness (Phase 2)Study completedNCT02190721
What this trial is testing

Evaluate 5 μg/kg Tbo-filgrastim in Infants, Children and Adolescents With Solid Tumors Without Bone Marrow Involvement

Who this might be right for
Neutropenia
Teva Branded Pharmaceutical Products R&D, Inc. 50
Early research (Phase 1)UnknownNCT06478381
What this trial is testing

L218CAR19 in Patients With Relapsed/Refractory B-cell Lymphoma

Who this might be right for
Relapsed/Refractory B-cell Lymphomas
Henan Cancer Hospital 22
Early research (Phase 1)Study completedNCT03018509
What this trial is testing

Study to Evaluate Safety,Tolerability,Pharmacodynamics & Pharmacokinetics of JTE-451 in Active Plaque Psoriasis Subjects

Who this might be right for
Plaque PsoriasisPsoriasisSkin Diseases
Akros Pharma Inc. 47
Testing effectiveness (Phase 2)Study completedNCT01128621
What this trial is testing

A Study in Type 2 Diabetic Subjects on Stable Metformin Therapy to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Co-administering Single and Multiple Oral Doses of GSK1292263

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 66
Early research (Phase 1)Looking for participantsNCT07535606
What this trial is testing

Evaluate ALN-4915 in Adult Healthy Volunteers

Who this might be right for
Healthy Volunteers
Alnylam Pharmaceuticals 44
Early research (Phase 1)Not Yet RecruitingNCT07768592
What this trial is testing

Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2511 in Participants With Early Alzheimer's Disease (AD)

Who this might be right for
Alzheimers Disease
Eisai Inc. 32
Early research (Phase 1)Study completedNCT02793232
What this trial is testing

Clinical Trial In Healthy Volunteers And Health Elderly Volunteers To Evaluate The Safety, Tolerability And Blood Concentration After Single And Multiple Escalating Oral Doses Of PF-06751979.

Who this might be right for
Healthy Subjects
Pfizer 46
Early research (Phase 1)Study completedNCT00622830
What this trial is testing

Phase I Study of SB-480848(Darapladib) -Repeat Dose Study in Healthy Japanese Male Subjects-

Who this might be right for
Atherosclerosis
GlaxoSmithKline 18
Early research (Phase 1)UnknownNCT04470063
What this trial is testing

Multi-dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DDO-3055 Tablets in Patients With Anemia of Non-dialysis Chronic Kidney Diseases.

Who this might be right for
Anemia Associated Chronic Kidney Disease
Jiangsu HengRui Medicine Co., Ltd. 30
Early research (Phase 1)Study completedNCT01212107
What this trial is testing

LY2874455 in Participants With Advanced Cancer

Who this might be right for
Advanced Cancer
Eli Lilly and Company 94
Next Page